These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12352279)

  • 1. Re: Clomipramine vs. Haloperidol in the treatment of autistic disorder: a double-blind, placebo, crossover study.
    King R; Fay G; Wheildon H
    J Clin Psychopharmacol; 2002 Oct; 22(5):525-6. PubMed ID: 12352279
    [No Abstract]   [Full Text] [Related]  

  • 2. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.
    Remington G; Sloman L; Konstantareas M; Parker K; Gow R
    J Clin Psychopharmacol; 2001 Aug; 21(4):440-4. PubMed ID: 11476129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of chronic pain symptoms with psychotropic drugs (author's transl)].
    Kocher R
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Nov; 9(6):337-41. PubMed ID: 64986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.
    Petracca G; Tesón A; Chemerinski E; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):270-5. PubMed ID: 8854297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF; Correa H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of live and videotape ratings: clomipramine and haloperidol in autism.
    Sanchez LE; Adams PB; Uysal S; Hallin A; Campbell M; Small AM
    Psychopharmacol Bull; 1995; 31(2):371-8. PubMed ID: 7491394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
    Kawahara T; Ueda Y; Mitsuyama Y
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomipramine treatment of delusional disorder, somatic type.
    Wada T; Kawakatsu S; Nadaoka T; Okuyama N; Otani K
    Int Clin Psychopharmacol; 1999 May; 14(3):181-3. PubMed ID: 10435772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of clomipramine in the treatment of canine compulsive disorder.
    Hewson CJ; Luescher UA; Parent JM; Conlon PD; Ball RO
    J Am Vet Med Assoc; 1998 Dec; 213(12):1760-6. PubMed ID: 9861971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
    Gordon CT; State RC; Nelson JE; Hamburger SD; Rapoport JL
    Arch Gen Psychiatry; 1993 Jun; 50(6):441-7. PubMed ID: 8498878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind trial of amineptine and clomipramine in the treatment of depression.
    Lemoine P; Achaintre A; Balvay G; Bonnet H; Burgat R; Carrier C; Perrin J
    Curr Med Res Opin; 1981; 7(4):234-40. PubMed ID: 7014104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
    Januel D; Poirier MF; D'alche-Biree F; Dib M; Olié JP
    J Affect Disord; 2003 Sep; 76(1-3):191-200. PubMed ID: 12943949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effect of clomipramine in chronic idiopathic pain disorder revisited using the Spielberger State Anxiety Symptom Scale (SSASS) as outcome scale.
    Bech P; Gormsen L; Loldrup D; Lunde M
    J Affect Disord; 2009 Dec; 119(1-3):43-51. PubMed ID: 19349078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of clomipramine hydrochloride in cats with psychogenic alopecia: a prospective study.
    Mertens PA; Torres S; Jessen C
    J Am Anim Hosp Assoc; 2006; 42(5):336-43. PubMed ID: 16960036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of psychotropic drugs in children.
    Morselli PL; Bianchetti G; Dugas M
    Pediatr Pharmacol (New York); 1983; 3(3-4):149-56. PubMed ID: 6146122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
    Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
    Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
    [No Abstract]   [Full Text] [Related]  

  • 19. Amineptine in the management of the depressive syndromes.
    Scarzella L; Scarzella R; Mailland F; Bergamasco B
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and of its combinations with haloperidol and diazepam.
    Cassano GB; Castrogiovanni P; Mauri M; Rutigliano G; Pirro R; Cerone G; Nielsen NP; Reitano S; Guidotti N; Bedarida D; Marchetti FP; Catalano A; Benecchi MV; Amabile G; Zanasi M; Pugliese L; Rocco ML; Balestrieri A; Tansella M; Burti L; Pariante F
    Prog Neuropsychopharmacol; 1981; 5(2):129-38. PubMed ID: 7022513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.